What this means
Researchers plan to follow men with prostate cancer and check three frailty screening tests. This is a registered study that is still recruiting, so no results are posted yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 65 and over
- Where
- 1 site
The science
- Registered title
- Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study
- Trial ID
- NCT07605936 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Frailty at Older Adults, Prostate Cancer
- Sponsor
- University of Limerick
- Ages
- 65 Years to no maximum
- Dates
- First posted May 26, 2026 · updated May 26, 2026
Registry summary
Prostate cancer is the most common solid tumour cancer amongst men in Ireland, with almost 4,000 new cases diagnosed annually and a median age at diagnosis of 67 years. The incidence of frailty amongst cancer patients is high. Among patients undergoing systemic anti-cancer therapy, frailty increases the risk of treatment related toxicity, hospitalisation, and death and is associated with a poorer quality of life.
This study aims to describe the demographic, clinical and frailty characteristics of men living with prostate cancer in the Mid-West of Ireland. In addition, we will assess the predictive accuracy of three frailty screening tools currently used in Irish clinical practice,G8, CFS and PRISMA 7, for predicting poorer outcomes at baseline, 6 and 12 months.
Sites (1)
- University Hospital Limerick, Limerick, Munster, Ireland